Biblio

Export 1093 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
C
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., “The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., “The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., “The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
A. Maes, Anthonissen, R., Wambacq, S., Simons, K., and Verschaeve, L., “The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 741-9, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., “Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
V. Yamamoto, Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., Sokolov, R., Wheeler, C., Kaushik, A., Elsayegh, A., Eliashiv, D., Hedrick, R., Jafari, B., J Johnson, P., Khorsandi, M., Gonzalez, N., Balakhani, G., Lahiri, S., Ghavidel, K., Amaya, M., Kloor, H., Hussain, N., Huang, E., Cormier, J., J Ashford, W., Wang, J. C., Yaghobian, S., Khorrami, P., Shamloo, B., Moon, C., Shadi, P., and Kateb, B., “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
V. Yamamoto, Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., Sokolov, R., Wheeler, C., Kaushik, A., Elsayegh, A., Eliashiv, D., Hedrick, R., Jafari, B., J Johnson, P., Khorsandi, M., Gonzalez, N., Balakhani, G., Lahiri, S., Ghavidel, K., Amaya, M., Kloor, H., Hussain, N., Huang, E., Cormier, J., J Ashford, W., Wang, J. C., Yaghobian, S., Khorrami, P., Shamloo, B., Moon, C., Shadi, P., and Kateb, B., “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
P. Alexopoulos, Soldatos, R., Kontogianni, E., Frouda, M., Aligianni, S. Loanna, Skondra, M., Passa, M., Konstantopoulou, G., Stamouli, E., Katirtzoglou, E., Politis, A., Economou, P., Alexaki, M., Siarkos, K., and Politis, A., “COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder.”, J Alzheimers Dis, vol. 79, no. 1, pp. 459-466, 2021.
P. Alexopoulos, Soldatos, R., Kontogianni, E., Frouda, M., Aligianni, S. Loanna, Skondra, M., Passa, M., Konstantopoulou, G., Stamouli, E., Katirtzoglou, E., Politis, A., Economou, P., Alexaki, M., Siarkos, K., and Politis, A., “COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder.”, J Alzheimers Dis, vol. 79, no. 1, pp. 459-466, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I., “COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
M. Golzari-Sorkheh, Weaver, D. F., and Reed, M. A., “COVID-19 as a Risk Factor for Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
N. Baazaoui and Iqbal, K., “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.”, J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., “Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
A. Kenne Malaha, Thébaut, C., Achille, D., Preux, P. - M., and Guerchet, M., “Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.”, J Alzheimers Dis, vol. 91, no. 1, pp. 115-128, 2023.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, “Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost.”, J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
N. Kandiah, Wang, V., Lin, X., Nyu, M. Mei, Lim, L., Ng, A., Hameed, S., and Wee, H. Lin, “Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost.”, J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.

Pages